These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

886 related articles for article (PubMed ID: 33199859)

  • 1. Ranking the effectiveness of worldwide COVID-19 government interventions.
    Haug N; Geyrhofer L; Londei A; Dervic E; Desvars-Larrive A; Loreto V; Pinior B; Thurner S; Klimek P
    Nat Hum Behav; 2020 Dec; 4(12):1303-1312. PubMed ID: 33199859
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The temporal association of introducing and lifting non-pharmaceutical interventions with the time-varying reproduction number (R) of SARS-CoV-2: a modelling study across 131 countries.
    Li Y; Campbell H; Kulkarni D; Harpur A; Nundy M; Wang X; Nair H;
    Lancet Infect Dis; 2021 Feb; 21(2):193-202. PubMed ID: 33729915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluating the impacts of non-pharmaceutical interventions on the transmission dynamics of COVID-19 in Canada based on mobile network.
    Xue L; Jing S; Wang H
    PLoS One; 2021; 16(12):e0261424. PubMed ID: 34965272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Effects of Non-pharmaceutical Interventions on COVID-19 Mortality: A Generalized Synthetic Control Approach Across 169 Countries.
    Mader S; Rüttenauer T
    Front Public Health; 2022; 10():820642. PubMed ID: 35444988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing the effect of non-pharmaceutical interventions on COVID-19 transmission in Spain, 30 August 2020 to 31 January 2021.
    García-García D; Herranz-Hernández R; Rojas-Benedicto A; León-Gómez I; Larrauri A; Peñuelas M; Guerrero-Vadillo M; Ramis R; Gómez-Barroso D
    Euro Surveill; 2022 May; 27(19):. PubMed ID: 35551707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating and explaining cross-country variation in the effectiveness of non-pharmaceutical interventions during COVID-19.
    Banholzer N; Feuerriegel S; Vach W
    Sci Rep; 2022 May; 12(1):7526. PubMed ID: 35534516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AI-assisted tracking of worldwide non-pharmaceutical interventions for COVID-19.
    Suryanarayanan P; Tsou CH; Poddar A; Mahajan D; Dandala B; Madan P; Agrawal A; Wachira C; Samuel OM; Bar-Shira O; Kipchirchir C; Okwako S; Ogallo W; Otieno F; Nyota T; Matu F; Barros VR; Shats D; Kagan O; Remy S; Bent O; Guhan P; Mahatma S; Walcott-Bryant A; Pathak D; Rosen-Zvi M
    Sci Data; 2021 Mar; 8(1):94. PubMed ID: 33767205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 case doubling time associated with non-pharmaceutical interventions and vaccination: A global experience.
    Liang LL; Kao CT; Ho HJ; Wu CY
    J Glob Health; 2021; 11():05021. PubMed ID: 34552726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Joint Analysis of the Epidemic Evolution and Human Mobility During the First Wave of COVID-19 in Spain: Retrospective Study.
    Steinegger B; Granell C; Rapisardi G; Gómez S; Matamalas J; Soriano-Paños D; Gómez-Gardeñes J; Arenas A
    JMIR Public Health Surveill; 2023 May; 9():e40514. PubMed ID: 37213190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COVID-19 non-pharmaceutical intervention portfolio effectiveness and risk communication predominance.
    Chan LYH; Yuan B; Convertino M
    Sci Rep; 2021 May; 11(1):10605. PubMed ID: 34012040
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential impact of non-pharmaceutical public health interventions on COVID-19 epidemics in the United States.
    Liu X; Xu X; Li G; Xu X; Sun Y; Wang F; Shi X; Li X; Xie G; Zhang L
    BMC Public Health; 2021 May; 21(1):965. PubMed ID: 34020613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transmission dynamics of the COVID-19 epidemic in England.
    Liu Y; Tang JW; Lam TTY
    Int J Infect Dis; 2021 Mar; 104():132-138. PubMed ID: 33359440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimating the effect of non-pharmaceutical interventions to mitigate COVID-19 spread in Saudi Arabia.
    Bisanzio D; Reithinger R; Alqunaibet A; Almudarra S; Alsukait RF; Dong D; Zhang Y; El-Saharty S; Herbst CH
    BMC Med; 2022 Feb; 20(1):51. PubMed ID: 35125108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Public Perceptions and Attitudes Toward COVID-19 Nonpharmaceutical Interventions Across Six Countries: A Topic Modeling Analysis of Twitter Data.
    Doogan C; Buntine W; Linger H; Brunt S
    J Med Internet Res; 2020 Sep; 22(9):e21419. PubMed ID: 32784190
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Harnessing Artificial Intelligence to assess the impact of nonpharmaceutical interventions on the second wave of the Coronavirus Disease 2019 pandemic across the world.
    Tao S; Bragazzi NL; Wu J; Mellado B; Kong JD
    Sci Rep; 2022 Jan; 12(1):944. PubMed ID: 35042945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What matters: non-pharmaceutical interventions for COVID-19 in Europe.
    Liu Y; Yu Q; Wen H; Shi F; Wang F; Zhao Y; Hong Q; Yu C
    Antimicrob Resist Infect Control; 2022 Jan; 11(1):3. PubMed ID: 35000583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Commentary on Ferguson, et al., "Impact of Non-pharmaceutical Interventions (NPIs) to Reduce COVID-19 Mortality and Healthcare Demand".
    Eubank S; Eckstrand I; Lewis B; Venkatramanan S; Marathe M; Barrett CL
    Bull Math Biol; 2020 Apr; 82(4):52. PubMed ID: 32270376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. COVID-19 pandemic spread against countries' non-pharmaceutical interventions responses: a data-mining driven comparative study.
    Xylogiannopoulos KF; Karampelas P; Alhajj R
    BMC Public Health; 2021 Sep; 21(1):1607. PubMed ID: 34470630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the effectiveness of government interventions against the resurgence of COVID-19 in Europe.
    Sharma M; Mindermann S; Rogers-Smith C; Leech G; Snodin B; Ahuja J; Sandbrink JB; Monrad JT; Altman G; Dhaliwal G; Finnveden L; Norman AJ; Oehm SB; Sandkühler JF; Aitchison L; Gavenčiak T; Mellan T; Kulveit J; Chindelevitch L; Flaxman S; Gal Y; Mishra S; Bhatt S; Brauner JM
    Nat Commun; 2021 Oct; 12(1):5820. PubMed ID: 34611158
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SARS-CoV-2 transmission dynamics in Belarus in 2020 revealed by genomic and incidence data analysis.
    Nemira A; Adeniyi AE; Gasich EL; Bulda KY; Valentovich LN; Krasko AG; Glebova O; Kirpich A; Skums P
    Commun Med (Lond); 2021; 1():31. PubMed ID: 35602211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.